These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of effects of rosuvastatin and atorvastatin on plaque regression in Korean patients with untreated intermediate coronary stenosis. Hong YJ; Jeong MH; Hachinohe D; Ahmed K; Choi YH; Cho SH; Hwang SH; Ko JS; Lee MG; Park KH; Sim DS; Yoon NS; Yoon HJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC Circ J; 2011; 75(2):398-406. PubMed ID: 21157106 [TBL] [Abstract][Full Text] [Related]
5. Comparison of effects of atorvastatin (20 mg) versus rosuvastatin (10 mg) therapy on mild coronary atherosclerotic plaques (from the ARTMAP trial). Lee CW; Kang SJ; Ahn JM; Song HG; Lee JY; Kim WJ; Park DW; Lee SW; Kim YH; Park SW; Park SJ Am J Cardiol; 2012 Jun; 109(12):1700-4. PubMed ID: 22440123 [TBL] [Abstract][Full Text] [Related]
6. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. Nissen SE; Nicholls SJ; Sipahi I; Libby P; Raichlen JS; Ballantyne CM; Davignon J; Erbel R; Fruchart JC; Tardif JC; Schoenhagen P; Crowe T; Cain V; Wolski K; Goormastic M; Tuzcu EM; JAMA; 2006 Apr; 295(13):1556-65. PubMed ID: 16533939 [TBL] [Abstract][Full Text] [Related]
9. Effect of two intensive statin regimens on progression of coronary disease. Nicholls SJ; Ballantyne CM; Barter PJ; Chapman MJ; Erbel RM; Libby P; Raichlen JS; Uno K; Borgman M; Wolski K; Nissen SE N Engl J Med; 2011 Dec; 365(22):2078-87. PubMed ID: 22085316 [TBL] [Abstract][Full Text] [Related]
10. C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapy. Puri R; Nissen SE; Libby P; Shao M; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Raichlen JS; Uno K; Kataoka Y; Nicholls SJ Circulation; 2013 Nov; 128(22):2395-403. PubMed ID: 24043299 [TBL] [Abstract][Full Text] [Related]
11. Effect of combination therapy of ezetimibe and rosuvastatin on regression of coronary atherosclerosis in patients with coronary artery disease. Masuda J; Tanigawa T; Yamada T; Nishimura Y; Sasou T; Nakata T; Sawai T; Fujimoto N; Dohi K; Miyahara M; Nishikawa M; Nakamura M; Ito M Int Heart J; 2015 May; 56(3):278-85. PubMed ID: 25902885 [TBL] [Abstract][Full Text] [Related]
12. Early intervention with rosuvastatin decreases the lipid components of the plaque in acute coronary syndrome: analysis using integrated backscatter IVUS (ELAN study). Otagiri K; Tsutsui H; Kumazaki S; Miyashita Y; Aizawa K; Koshikawa M; Kasai H; Izawa A; Tomita T; Koyama J; Ikeda U Circ J; 2011; 75(3):633-41. PubMed ID: 21266787 [TBL] [Abstract][Full Text] [Related]
13. Impact of baseline lipoprotein and C-reactive protein levels on coronary atheroma regression following high-intensity statin therapy. Puri R; Nissen SE; Shao M; Uno K; Kataoka Y; Kapadia SR; Tuzcu EM; Nicholls SJ Am J Cardiol; 2014 Nov; 114(10):1465-72. PubMed ID: 25282317 [TBL] [Abstract][Full Text] [Related]
14. Influence of high-dose lipid lowering treatment compared to low-dose lipid lowering treatment on plaque composition assessed by intravascular ultrasound virtual histology in patients with ST-segment elevation acute myocardial infarction: the VIRHISTAMI trial. Egede R; Jensen LO; Hansen HS; Hansen KN; Junker A; Thayssen P EuroIntervention; 2013 Feb; 8(10):1182-9. PubMed ID: 22987572 [TBL] [Abstract][Full Text] [Related]
15. Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study. Räber L; Taniwaki M; Zaugg S; Kelbæk H; Roffi M; Holmvang L; Noble S; Pedrazzini G; Moschovitis A; Lüscher TF; Matter CM; Serruys PW; Jüni P; Garcia-Garcia HM; Windecker S; Eur Heart J; 2015 Feb; 36(8):490-500. PubMed ID: 25182248 [TBL] [Abstract][Full Text] [Related]
16. Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden. Ballantyne CM; Raichlen JS; Nicholls SJ; Erbel R; Tardif JC; Brener SJ; Cain VA; Nissen SE; Circulation; 2008 May; 117(19):2458-66. PubMed ID: 18378607 [TBL] [Abstract][Full Text] [Related]
17. Effect of Statin Treatment on Modifying Plaque Composition: A Double-Blind, Randomized Study. Park SJ; Kang SJ; Ahn JM; Chang M; Yun SC; Roh JH; Lee PH; Park HW; Yoon SH; Park DW; Lee SW; Kim YH; Lee CW; Mintz GS; Han KH; Park SW J Am Coll Cardiol; 2016 Apr; 67(15):1772-1783. PubMed ID: 27081016 [TBL] [Abstract][Full Text] [Related]
18. Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial. Hirohata A; Yamamoto K; Miyoshi T; Hatanaka K; Hirohata S; Yamawaki H; Komatsubara I; Murakami M; Hirose E; Sato S; Ohkawa K; Ishizawa M; Yamaji H; Kawamura H; Kusachi S; Murakami T; Hina K; Ohe T J Am Coll Cardiol; 2010 Mar; 55(10):976-82. PubMed ID: 20202514 [TBL] [Abstract][Full Text] [Related]
19. Effects of Combination of Ezetimibe and Rosuvastatin on Coronary Artery Plaque in Patients with Coronary Heart Disease. Wang X; Zhao X; Li L; Yao H; Jiang Y; Zhang J Heart Lung Circ; 2016 May; 25(5):459-65. PubMed ID: 26687339 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the Effect of Rosuvastatin 2.5 mg vs 20 mg on Coronary Plaque Determined by Angioscopy and Intravascular Ultrasound in Japanese With Stable Angina Pectoris (from the Aggressive Lipid-Lowering Treatment Approach Using Intensive Rosuvastatin for Vulnerable Coronary Artery Plaque [ALTAIR] Randomized Trial). Takayama T; Komatsu S; Ueda Y; Fukushima S; Hiro T; Hirayama A; Saito S; Am J Cardiol; 2016 Apr; 117(8):1206-12. PubMed ID: 26879069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]